NuVasive, Inc.
NUVA
NUVA was delisted on the 31st of August, 2023.
2 hedge funds and large institutions have $9.55K invested in NuVasive, Inc. in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 223 closing their positions.
99% less funds holding
Funds holding: 228 → 2 (-226)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $2.39B → $9.55K (-$2.39B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 223
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$365M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$246M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$101M |
| 4 |
KC
Kryger Capital
London,
United Kingdom
|
-$98.3M |
| 5 |
State Street
Boston,
Massachusetts
|
-$92.3M |
NUVA Hedge Fund Activity: Q3 2023 in Review
2 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in NuVasive, Inc. (NUVA) for Q3 2023, worth a combined $9.55K — down 100% from $2.39B a quarter earlier.
Sellers outnumbered buyers: 223 funds closed out of NUVA and 0 opened new positions — a net loss of 223 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $365M sold.
- 2 institutional investors held NuVasive, Inc. (NUVA) as of Q3 2023, down from 228 in Q2 2023.
- Funds reported $9.55K of NuVasive, Inc. stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new NuVasive, Inc. positions in Q3 2023 and 223 closed out, a net change of -223 holders.
- The largest NuVasive, Inc. seller in Q3 2023 was BlackRock, an estimated $365M sold.
Based on aggregated 13F filings for Q3 2023.